Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Profound Medical (PROF)
NASDAQ:PROF
Profound Medical (PROF) Ownership - Who Owns Profound Medical?
53 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 23, 2023 | Arun Menawat Chairman & Chief Executive Officer | Bought | C$219174 |
| Dec 23, 2023 | Arun Menawat Chairman & Chief Executive Officer | Bought | C$318026 |
| Dec 23, 2023 | Mathieu Burtnyk Senior Officer | Bought | C$40988 |
| Dec 23, 2023 | Mathieu Burtnyk Senior Officer | Bought | C$77090 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,441,792 | Insider | 55.02% | 114,658,486 | |
| 11,828,144 | Insider | 48.42% | 100,894,068 | |
| 11,828,144 | Insider | 48.42% | 100,894,068 | |
| 7,400,000 | Insider | 30.29% | 63,122,000 | |
| 564,298 | Institution | 2.31% | 4,813,462 | |
| 462,443 | Insider | 1.89% | 3,944,639 | |
| 279,398 | Institution | 1.14% | 2,383,265 | |
| 95,800 | Institution | 0.39% | 817,174 | |
| 68,000 | Insider | 0.28% | 580,040 | |
| 23,747 | Insider | 0.10% | 202,562 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 279,398 | Institution | 1.14% | 2,383,265 | |
| 95,800 | Institution | 0.39% | 817,174 | |
| 11,639 | Institution | 0.05% | 99,281 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Profound Medical (PROF)?
Currently, no data Available
What percentage of Profound Medical (PROF) stock is held by institutional investors?
Currently, no data Available
What percentage of Profound Medical (PROF) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Profound Medical (PROF)?
Bdc owns the most shares of Profound Medical (PROF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.